These results, along with a prior report showing that a little-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like conduct in mice,2 help the concept of focusing on ACKR3 as a novel solution to modulate the opioid system, which could open up new therapeutic avenues for opioid-related Issues. At that time, Microsoft https://georgel516vcg9.elbloglibre.com/profile